SCHEMBL10072246

SCHEMBL10072246

CC(C)C[C@@](C)(NCc1ccc(/C=C/C(=O)NO)cc1)C(=O)OC1CCOC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 15/20 0.41
HDAC3 O15379 14/20 0.41
HDAC8 Q9BY41 12/20 0.41
HDAC6 Q9UBN7 7/20 0.41
HDAC4 P56524 5/20 0.41
HDAC5 Q9UQL6 5/20 0.41
HDAC2 Q92769 12/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNH2 Q12809 1/20 0.38
KDM1A O60341 3/20 0.38
MEF2D Q14814 1/20 0.37
MAOA P21397 1/20 0.37
HDAC7 Q8WUI4 3/20 0.36
HDAC10 Q969S8 3/20 0.36
HDAC11 Q96DB2 3/20 0.36
HDAC9 Q9UKV0 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705567 1.00 HDAC1 (0.41) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL2705563 1.00 HDAC1 (0.41) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL9895637 0.88 HDAC3 (0.49) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL9895636 0.88 HDAC3 (0.49) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL7897836 0.88 HDAC3 (0.49) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL10072244 0.88 SMN1; SMN2 (0.35) HDAC1HDAC3HDAC8HDAC6HDAC4
Trifluoroacetic Acid SCHEMBL9904047 0.83 HDAC3 (0.45) HDAC1HDAC3HDAC8HDAC6HDAC4
Trifluoroacetic Acid SCHEMBL9895157 0.83 HDAC3 (0.45) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL2707166 0.77 HDAC8 (0.53) HDAC1HDAC3HDAC8HDAC6HDAC4
SCHEMBL2707161 0.77 HDAC8 (0.53) HDAC1HDAC3HDAC8HDAC6HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed